Rational Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Rational Advisors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-89	Closed	-$4K	–	404
2020 Q3	$4K	Buy	+89	New	+$4.94K	﹤0.01%	401

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Rational Advisors's IONS Position: Q4 2020 in Review

Rational Advisors sold out of Ionis Pharmaceuticals (IONS) in Q4 2020, closing a stake of 89 shares — an estimated $4K sold.

Rational Advisors first reported a position in IONS in Q3 2020 and held it in 1 quarter. The position peaked at $4K in Q3 2020. 382 funds tracked by Wall St. Rank hold IONS as of Q4 2020.

Rational Advisors reported no remaining Ionis Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Rational Advisors sold 89 Ionis Pharmaceuticals shares in Q4 2020, an estimated $4K.
Rational Advisors first reported a position in Ionis Pharmaceuticals in Q3 2020 and held it in 1 quarter.
Rational Advisors's Ionis Pharmaceuticals position peaked at $4K in Q3 2020.
382 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2020.

Based on Rational Advisors's 13F filing for Q4 2020, filed 5 Feb 2021.